Search results
Showing 3286 to 3300 of 7691 results
Agenda and papers of the NICE public board meeting on 20 March 2024
Interventional procedures register an interest form Sign up to receive email updates on interventional procedures guidance. We'll let you know when:...
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
We use the best available evidence to develop guidance to improve health and social care. Our guidance takes many forms. From this page, you can find
Find out more about the members of Quality standards advisory committee members by reading their biographies. Dr Rebecca Payne Chair General...
Find out more about the members of Quality standards advisory committee members by reading their biographies. Dr Rebecca Payne Chair General...
The quality standards advisory committee (QSAC) is an independent committee that helps to develop our quality standards . Come to a meeting Committee
Immunisation: flu vaccine for people with long-term conditions (IND152)
This indicator covers the percentage of patients with coronary heart disease, stroke or transient ischemic attack, diabetes and/or chronic obstructive pulmonary disease who have influenza immunisation in the preceding 1 August to 31 March. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM122
Charging procedure: technology appraisal and highly specialised technologies evaluations
Introduction In accordance with UK Statutory Instrument 2018 No.1322 , NICE must recover its costs for producing Technology Appraisals (TA) or Highly
Charging procedure: technology appraisal and highly specialised technologies evaluations
Introduction In accordance with UK Statutory Instrument 2018 No.1322 , NICE must recover its costs for producing Technology Appraisals (TA) or Highly
Support for industry to engage with NICE during all stages of health technology development
The Commercial Liaison Team (CLT) works with companies who are considering a patient access scheme for their drug or treatment. Patient access schemes
Role and responsibilities of the National Institute of Health and Care Excellence
Artificial intelligence (AI) and digital regulations service
NICE's leading role in designing a new service to support the development and adoption of AI and data-driven technologies in health and care.
How we collect and use your personal information, and your rights under data protection legislation